The goal of our laboratory is to improve the treatment and survival of children with neuroblastoma, medulloblastoma and rhabdomyosarcoma, three paediatric solid tumours in which high-risk patient ...

Our group's aim is to improve the treatment and survival of children with neuroblastoma, medulloblastoma and rhabdomyosarcoma. The goal of our laboratory is to improve the treatment and survival of ...

The Institute of Cancer Research, London, has welcomed the approval of a new combination of two drugs for ovarian cancer by the US regulatory body the Food and Drug Administration (FDA). The approval ...

Researchers at The Institute of Cancer Research, London, have uncovered a hidden weakness in some breast cancer tumours that could lead to smarter treatment decisions. One of the body’s natural ...

In April 2019, Claire Shepherd, now 34, began feeling unwell and constantly fatigued. Having initially put her symptoms down to her hectic lifestyle, she was shocked to be diagnosed with acute myeloid ...

The Magnetic Resonance group develops and tests new probes, instrumentation and techniques to better plan and assess cancer treatment. Our research is principally focused on the further development ...